Last reviewed · How we verify
Focetria®
Focetria is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against influenza virus strains.
Focetria is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against influenza virus strains. Used for Seasonal influenza prevention in adults and children.
At a glance
| Generic name | Focetria® |
|---|---|
| Sponsor | Chiltern Pesquisa Clinica Ltda |
| Drug class | Inactivated influenza vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology / Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
Focetria is a split-virion, inactivated influenza vaccine containing antigens from three influenza virus strains (trivalent formulation). It works by presenting viral antigens to the immune system, triggering both humoral (antibody) and cellular immune responses that provide protection against infection with the included influenza strains. The vaccine is administered intramuscularly and is designed to prevent seasonal influenza infection.
Approved indications
- Seasonal influenza prevention in adults and children
Common side effects
- Injection site reactions (pain, redness, swelling)
- Myalgia
- Headache
- Fever
- Fatigue
Key clinical trials
- Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus (PHASE3)
- Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection (PHASE3)
- A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Focetria® CI brief — competitive landscape report
- Focetria® updates RSS · CI watch RSS
- Chiltern Pesquisa Clinica Ltda portfolio CI